Physician profile
Brian J Page
NPI 1700028933
$783.48
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.42 · 2020: $287 · 2021: $99.61 · 2022: $251 · 2023: $95.94 · 2024: $20.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.31 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.31 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $271.94 | 2020-2023 | Farxiga |
| Amgen INC. | $140.79 | 2021-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.19 | 2020-2021 | |
| Abiomed | $57.28 | 2020-2022 | |
| Novo Nordisk INC | $35.10 | 2022 | |
| Astellas Pharma US INC | $29.42 | 2019 | |
| Boston Scientific Corporation | $27.58 | 2021 | |
| Edwards Lifesciences Corporation | $25.95 | 2020 | |
| Pfizer INC. | $23.78 | 2023 | |
| Medtronic, INC. | $20.63 | 2024 | Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $12.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.